Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Translational Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Noreen Kamal | Dalhousie University | Canada

Dr. Noreen Kamal, Ph.D., P.Eng., is an Associate Professor of Industrial Engineering at Dalhousie University, Canada, with cross-appointments in the Departments of Community Health and Epidemiology and Medicine (Neurology). Her research lies at the intersection of health systems engineering and clinical neuroscience, focusing on the optimization of stroke care systems, development of data-driven quality improvement frameworks, and evaluation of biomedical devices for stroke rehabilitation. Dr. Kamal has played a pivotal role in advancing integrated approaches to enhance the efficiency, safety, and accessibility of acute stroke services across Canada. Prior to joining Dalhousie University, she held academic and leadership positions at the University of Calgary and the University of British Columbia, contributing extensively to clinical research and health technology innovation. Her work bridges engineering, medicine, and health policy, emphasizing interdisciplinary collaboration and patient-centered outcomes. With 107 scientific publications, 8,033 citations, and an h-index of 22, Dr. Kamal has established herself as a recognized scholar in healthcare systems improvement and translational neuroscience. Her scholarly and professional contributions continue to drive evidence-based innovation in stroke systems of care, supporting better clinical outcomes and sustainable health service delivery.

Profiles: Scopus | Google Scholar | Research Gate | Linked In

Featured Publications

Author(s). (2025). Exploring differences in stroke treatment between urban and rural hospitals: A thematic analysis of practices in Canada. Canadian Journal of Neurological Sciences.

Author(s). (2025). Designing a patient outcome clinical assessment tool for modified Rankin Scale: “You feel the same way too”. Informatics.

Author(s). (2025). Predicting ischemic stroke patients to transfer for endovascular thrombectomy using machine learning: A case study. Healthcare (Switzerland).

Author(s). (2025). Incident prescriptions for common cardiovascular medications: Comparison of recent versus pre-2020 medication adherence and discontinuation in three universal health care systems. BMC Cardiovascular Disorders.

Author(s). (2025). Rising out-of-hospital mortality in Canada during 2020–2022: A striking impact observed among young adults. Canadian Journal of Public Health.

Author(s). (2025). Discrete event simulation model of an acute stroke treatment process at a comprehensive stroke center: Determining the ideal improvement strategies for reducing treatment times. Journal of the Neurological Sciences.

Author(s). (2025). Validation of the Passive Surveillance Stroke Severity Score in three Canadian provinces. Canadian Journal of Neurological Sciences.

Author(s). (2025). A stochastic optimization model for designing disaster relief networks with congestion, disruption and distributional ambiguity. Infor.

Author(s). (2025). Improving access and efficiency of acute ischemic stroke treatment across four Canadian provinces: A stepped-wedge trial. Frontiers in Neurology.

Author(s). (2025). The acute stroke system of treatment across Canada: Findings from a national stroke centre survey. Canadian Journal of Neurological Sciences.

Nasar Ata | Neurology | Best Researcher Award

Mr. Nasar Ata | Neurology | Best Researcher Award

Dr. S. M. Nasar Ata is a researcher in the Department of Neurology at Henry Ford Hospital, Detroit, USA, specializing in artificial intelligence applications in neuroscience. His work focuses on developing machine learning and soft computing–based algorithms such as CNN, ANN, SVM, and MLR for detecting and predicting brain-based disorders, including Multiple Sclerosis. He integrates metabolomics and imaging clinical data to identify biomarkers and construct predictive models for neurological and metabolic diseases. Dr. Ata collaborates with research centers such as JNMC and IBRC AMU on brain tumor prediction from MRI data and with RCDR AMU on diabetes-related model development. His research contributions include several submitted papers on metabolite prediction, deep learning in brain tumor detection, and molecular mechanisms underlying neurodegeneration and cancer. He has also authored the textbook Basics of Bio-Sciences and actively participates in scientific discussions and editorial work. With 3 published documents, 7 citations, and an h-index of 2, Dr. Ata’s growing research profile reflects his commitment to advancing data-driven neurological diagnostics through AI and biostatistical innovation.

Profiles: Scopus | Research Gate

Featured Publication

Corrigendum to “Artificial neural network-based prediction of multiple sclerosis using blood-based metabolomics data” [Multiple Sclerosis and Related Disorders, 92, 105942 (2024)]. (2024). Multiple Sclerosis and Related Disorders, 95, 106321.

Thais Reis Lage Nunes | Stroke | Best Researcher Award

Ms. Thais Reis Lage Nunes | Stroke | Best Researcher Award

Universidade Federal de Minas Gerais | Brazil

Thais Aparecida Reis Lage is a Brazilian physician and neurologist with a background in clinical cardiology and stroke in Chagas disease, and expertise in internist medicine. She earned her medical degree from the Universidade Federal de Minas Gerais and completed specialization in neurology, followed by a master’s in Infectious and Tropical Medicine where she studied factors associated with ischemic stroke in patients with Chagas cardiomyopathy. Her professional experience includes roles as internist, emergency clinician, and neurologist at various institutions in Belo Horizonte, and she is also active in hospital work via public service and part-time positions. She has contributed to scientific literature, including a paper on a murine model studying brain, behavior, and immunity during hepatic encephalopathy. According to available bibliometric sources, she has 8 documents and 1 citation, with an h-index of 5. She is fluent in Portuguese and English, with functional proficiency in Spanish, and is involved in medical and academic activities including teaching, research, and hospital practice. She lives in Belo Horizonte and conducts her professional work primarily tied to Universidade Federal de Minas Gerais and associated hospitals.

Profiles: Scopus

Featured Publications

“Predictors of ischemic stroke in Chagas disease: Insights into mechanisms beyond cardiomyopathy severity”

Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Georgia Kaiafa, Medical School, Aristotle University of Thessaloniki,  Greece.

Dr. Georgia Kaiafa is a distinguished hematologist and academician whose career spans clinical excellence, impactful research, and dedicated teaching. A graduate of Aristotle University of Thessaloniki, she earned her MBBS in 1987, Board Certification in Hematology in 1996, and completed her Doctorate in 2005. Her academic roles have progressed from Lecturer to Associate Professor of Hematology and Thromboembolic Diseases, with a longstanding association at AHEPA University Hospital.

Profile

Scopus

 

🎓 Early Academic Pursuits

Georgia Kaiafa began her academic journey in medicine at the prestigious Aristotle University of Thessaloniki, enrolling in the Medical School in 1980. Her foundational training was marked by determination and intellectual rigor, culminating in the completion of her MBBS in 1987. A steadfast commitment to advanced education led her to earn her Board Certification in Haematology by 1996, and later, she successfully defended her Doctorate thesis in 2005. These formative years reflect her deep-rooted passion for understanding hematological science and its clinical applications.

🧬 Professional Endeavors in Hematology

Her professional journey has been nothing short of inspiring, anchored in both clinical excellence and academic growth. Georgia Kaiafa has served in several academic ranks, beginning as a Lecturer in Hematology from 2007 to 2015, advancing to Assistant Professor until 2021, and currently holding the esteemed position of Associate Professor of Hematology and Thromboembolic Diseases. She is affiliated with AHEPA University Hospital’s Hematology Department, a major center of excellence in Greece. Her expertise was further enriched by her tenure as a Visiting Research Associate at King’s College Hospital in London in 2012, where she gained valuable international exposure. Since 2005, she has also played a leadership role as a Coordinator in the Northern Greece Office of the Health Sector, bridging academic medicine and healthcare policy.

🩸 Contributions and Research Focus

Georgia Kaiafa has devoted her scholarly efforts to advancing the understanding of thrombosis, thromboembolic disorders, and hematological malignancies. With her contributions to over 95 peer-reviewed international journal publications and participation as a Principal Investigator in 26 research trials, she has carved out a niche in evidence-based hematological research. Her investigations have deeply influenced protocols and practices in vascular pharmacology, hematologic diagnostics, and the clinical management of thrombotic conditions. She is also a prominent educator, mentoring Ph.D. candidates and contributing to postgraduate programs for both Greek and international students.

🏆 Accolades and Recognition

Her scientific contributions have not gone unnoticed. Georgia Kaiafa has received significant national acclaim, including the 1st Prize Award for Best Paper at the Pan-Hellenic Haematology Conference in 2008 and again at the 1st Conference of Internal Medicine of Northern Greece in 2015. These accolades affirm her research excellence and clinical insight. Her expertise has earned her memberships in elite national and international medical societies, including the Hellenic Stroke Organization and the European Stroke Organization, as well as a respected position in the Excellence of Thrombosis initiative.

🌍 Impact and Influence

Beyond academia and clinical service, Kaiafa has exerted influence on multiple scientific fronts. As a reviewer for prominent journals such as Thrombosis Research, Anemia, Case Reports in Hematology, and the Indian Heart Journal, she ensures high scientific standards in hematologic research worldwide. Her editorial work for both international and Greek journals demonstrates her authority in the field and her dedication to the progression of scientific communication. Her wide-ranging collaborations and committee leadership roles have significantly influenced health education and medical research in Greece and abroad.

📚 Scholarly Engagement and Mentorship

Georgia Kaiafa is not only a prolific researcher but also a passionate mentor and academic contributor. With 23 chapters in medical books, over 130 abstracts in Greek conference proceedings, and nearly 100 abstracts presented in international forums, her voice resonates across the global hematology community. She has mentored and supervised numerous doctoral students, serving on committees for 12 Ph.D. projects and directly supervising five, cultivating the next generation of scientific minds. She has also chaired 22 congress sessions and delivered more than 100 invited talks, emphasizing her respected role as both speaker and thought leader.

🔬 Legacy and Future Contributions

As a seasoned academic and clinical researcher, Georgia Kaiafa continues to shape the future of hematology in Greece and beyond. Her legacy lies in her dual commitment to clinical care and scientific discovery, especially in the realm of thromboembolic diseases and hematologic innovations. Her ongoing involvement in research protocols, editorial responsibilities, and student mentorship assures that her influence will persist. With a solid foundation and a career marked by excellence, her future contributions are likely to further impact hematological sciences and translational medicine globally.

publication

 

  • Title: Monocyte Chemoattractant Protein-1 as a Biomarker in Acute Ischemic Stroke: A Prospective Pilot Study
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Prospective Study of ADAMTS13 and von Willebrand Factor’s Role in the Prediction of Outcomes in Acute Ischemic Stroke
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Antiphospholipid Syndrome: A Comprehensive Clinical Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: The Seasonal Distribution of Immune Thrombotic Thrombocytopenic Purpura is Influenced by Geography: Epidemiologic Findings from a Multi-Center Analysis of 719 Disease Episodes
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Outpatient Management After Hospitalisation for Acute Decompensation of Cirrhosis: A Practical Guide
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Thyroid Disease and Systemic Lupus Erythematosus
    Author(s): [Not specified]
    Year: 2023

 

🏁 Conclusion

Dr. Georgia Kaiafa embodies the values of academic integrity, scientific advancement, and clinical leadership. Her commitment to both national healthcare development and international scientific collaboration sets her apart. With a strong foundation in research, education, and public health, she not only meets but exceeds the criteria for recognition through the Best Researcher Award. Her body of work stands as a testament to sustained excellence and future promise in hematology and related disciplines.

Wang Yanqiang | Stroke | Best Researcher Award

Prof. Wang Yanqiang | Stroke | Best Researcher Award

Prof. Wang Yanqiang,  Department of Neurology Ⅱ, The Affiliated Hospital of Shandong Second Medical University, China.

Dr. Yanqiang Wang is a distinguished neurologist and researcher specializing in ischemic brain injury, Parkinson’s disease, and cerebrovascular disorders. With an extensive academic background and international research experience, he has significantly contributed to the understanding and treatment of neurological diseases. Currently serving at the Affiliated Hospital of Weifang Medical University, his work continues to influence the global medical community.

 

Profile

Orcid

 

🎓 Early Academic Pursuits: A Strong Foundation in Neurology

Dr. Wang embarked on his academic journey at Xu Zhou Medical University, where he earned a Master’s degree in Neurology (2003-2006). His early research delved into the pathogenesis of Parkinson’s disease, igniting a passion for neurodegenerative disorders. Determined to further his expertise, he pursued a Ph.D. at Sun Yat-sen University (2012-2015), where he conducted groundbreaking research on ischemic stroke and neuromyelitis optica spectrum disorders. His academic endeavors laid the foundation for his illustrious career in neurology.

🏥 Professional Endeavors: Bridging Clinical Practice and Research

Dr. Wang’s medical career commenced at the Affiliated Hospital of Weifang Medical University, where he served as a resident and attending doctor in the Department of Immunology and Rheumatology (2006-2012). He later transitioned to neurology, assuming key roles at Shandong Second Medical University, where he currently serves as a director. His expertise in cerebrovascular diseases, particularly ischemic stroke, has led to significant advancements in patient care and treatment methodologies. In 2020, he expanded his horizons internationally as Vice-Director in the Department of Neurology at the University of Washington, USA, where he collaborated with leading researchers in cerebrovascular disease.

🎡 Contributions and Research Focus: Advancing Neurological Science

Throughout his career, Dr. Wang has remained committed to unraveling the complexities of neurological disorders. His research primarily focuses on the pathogenesis and neuroprotection of ischemic brain injury and Parkinson’s disease. His postdoctoral work at Xuzhou Medical University (2016-2019) further solidified his contributions to stroke research, offering new insights into treatment strategies. His clinical studies on neuromyelitis optica spectrum disorders have expanded the scientific community’s understanding of autoimmune neurological conditions.

🏆 Accolades and Recognition: Acknowledged for Excellence

Dr. Wang’s dedication to neurology has earned him numerous accolades, both nationally and internationally. His research publications in high-impact journals have been widely cited, influencing contemporary neurological studies. His leadership roles in various medical institutions and his tenure at the University of Washington further attest to his global recognition in the field. His contributions to stroke and neurodegenerative disease research have been acknowledged through invitations to prestigious medical conferences and collaborative research initiatives.

👁 Impact and Influence: Shaping the Future of Neurology

As a clinician, researcher, and mentor, Dr. Wang has had a profound impact on the medical community. His pioneering studies have improved diagnostic and therapeutic approaches for cerebrovascular diseases. By integrating research with clinical practice, he has enhanced patient outcomes and influenced future neurological research directions. His mentorship of young medical professionals and researchers ensures the continued advancement of neurology as a field.

🌱 Legacy and Future Contributions: Paving the Way for Innovations

Dr. Wang’s legacy lies in his relentless pursuit of excellence in neurology. His ongoing research on ischemic stroke and Parkinson’s disease continues to shape the future of neurological science. With a vision for innovation, he aims to develop novel therapeutic interventions that can transform the treatment landscape for cerebrovascular and neurodegenerative disorders. His contributions will undoubtedly leave an enduring mark on the field, inspiring future generations of neurologists and researchers.

Publication

  • Inhibition of the cGAS–STING pathway: contributing to the treatment of cerebral ischemia-reperfusion injury
    Authors: Yanghang Yang, Yulei Xia, Yue Ma, Mingtong Gao, Shuai Hou, Shanshan Xu, Yanqiang Wang
    Year: 2025

 

  • Exploring the Neuroprotective Effects of Lithium in Ischemic Stroke: A Literature Review
    Authors: Weihua Wang, Dunlin Lu, Youkui Shi, Yanqiang Wang
    Year: 2024

 

  • Risk Factors and Clinical Characteristics of First-ever Ischemic Stroke Caused by ICAS with Leukoaraiosis
    Authors: Xiaopan Liu, Ning Wu, Jian Li, Meng Pang, Yaozhen Wang, Yuge Wang, Shuai Jia, Yanqiang Wang
    Year: 2024

 

  • 1,25-D3 ameliorates ischemic brain injury by alleviating endoplasmic reticulum stress and ferroptosis: Involvement of vitamin D receptor and p53 signaling
    Authors: Ting Song, Jian Li, Yulei Xia, Shuai Hou, Xiaojun Zhang, Yanqiang Wang
    Year: 2024

 

  • A case of acute basilar artery occlusion due to atherosclerotic disease revascularized by drug-coated balloon dilation
    Authors: Yingzhe Zhao, Shuai Jia, Jian Li, Jianhong Geng, Yanqiang Wang, Xiaomei Cui
    Year: 2024

 

  • A case report of drug-coated balloon dilation angioplasty in a patient with acute atherosclerotic basilar artery occlusion
    Authors: Xiaomei Cui, Yong-Deng Li, Shuai Jia, Yan-Qiang Wang
    Year: 2024

 

  • Global, regional, and national epidemiology of ischemic stroke from 1990 to 2021
    Authors: Shuai Hou, Yifeng Zhang, Yulei Xia, Yong Liu, Xia Deng, Weihua Wang, Yanqiang Wang, Chunping Wang, Gang Wang
    Year: 2024

 

  • Genetic insights into the relationship between immune cell characteristics and ischemic stroke: A bidirectional Mendelian randomization study
    Authors: Xia Deng, Shuai Hou, Yanqiang Wang, Haiyan Yang, Chunping Wang
    Year: 2024

 

  • Assessing tobacco-related ischemic stroke in Pakistan (1990-2019): Insights from the Global Burden of Disease Study
    Authors: Shuai Hou, Pang M, Zhang Y, Xia Y, Wang Y, Wang G
    Year: 2024

 

  • First report of a p.Cys484Tyr Notch3 mutation in a CADASIL patient with acute bilateral multiple subcortical infarcts—case report and brief review
    Authors: Weili Liu, Jie Zhang, Jian Li, Shuai Jia, Yanqiang Wang, Jianhong Geng, Yaozhen Wang
    Year: 2024

 

💡 Conclusion

Dr. Yanqiang Wang’s career exemplifies dedication, innovation, and leadership in neurology. From his early academic endeavors to his global contributions, he has continuously pushed the boundaries of medical science. His work not only benefits current patients but also paves the way for future breakthroughs in neurological research. As he continues to explore new frontiers in neuroscience, his impact on the medical community remains unparalleled.

 

 

Jing Sun | Cerebrovascular disease | Best Researcher Award

Dr. Jing Sun | Cerebrovascular disease | Best Researcher Award

Dr. Jing Sun, China-Japan Union Hospital of Jilin University, China.

Dr. Jing Sun, a prominent researcher and attending physician at the China-Japan Union Hospital of Jilin University, has made significant contributions to the field of neurology, particularly in the areas of cerebrovascular diseases and cognitive disorders. She earned her Doctor of Medicine degree from Jilin University in 2017 and has since focused her research on understanding the molecular mechanisms behind stroke, neuroinflammation, and brain injury. Her work has been widely published, with over 10 SCI papers, many of which highlight her pioneering research on the MAPK signaling pathway and NLRP3 inflammasome in neurological disorders.

 

profile

Orcid

Early academic pursuits 🎓

Dr. Jing Sun’s academic journey began at Jilin University, one of China’s leading institutions for medical education. She earned her Master’s degree in Neurology from the First Affiliated Hospital of Jilin University in 2013, where she honed her foundational knowledge in neuroscience. Her pursuit of deeper insights into the human brain led her to continue at Jilin University for her Doctor of Medicine degree, which she successfully obtained in 2017. Her academic curiosity and dedication during her early years in medicine shaped her future focus on cerebrovascular and cognitive disorders. It was here that she began to appreciate the complexity of neurological diseases and developed an intense interest in stroke and its associated pathophysiology.

Professional endeavors in cerebrovascular research 🧠

Following her graduation, Dr. Sun embarked on her professional career at the China-Japan Union Hospital of Jilin University, where she has been an attending physician since 2017. Her clinical practice centers on cerebrovascular diseases and cognitive impairments, which are crucial areas of study in modern neurology. As an attending physician, Dr. Sun not only engages with patients but also leads research on stroke, neuroinflammation, and neurovascular unit damage. Her combination of hands-on clinical experience and a deep passion for research has allowed her to bridge the gap between theoretical understanding and practical application, significantly advancing her research on neurological diseases.

Contributions and research focus 🔬

Dr. Sun’s research is primarily focused on cerebrovascular and cognitive disorders, with an emphasis on understanding the molecular pathways that lead to brain injuries such as strokes and neuroinflammation. She has explored the role of the mitogen-activated protein kinase (MAPK) signaling pathway as a potential target for stroke therapies, contributing significantly to the understanding of molecular mechanisms behind neurological diseases. Her work extends to investigating neuroinflammatory processes, specifically the NLRP3 inflammasome, and how it contributes to brain injury and dysfunction after stroke. Dr. Sun’s research findings have been published in top-tier journals, with several of her papers listed as first or corresponding author contributions.

Impact and recognition in the research community 🌍

Dr. Sun’s contributions to the field of neurology have not gone unnoticed. She has published more than 10 scientific papers in esteemed peer-reviewed journals, with many of them focusing on key aspects of cerebrovascular disease and neuroinflammation. Her work on the MAPK signaling pathway and the role of the NLRP3 inflammasome in neurological disorders has garnered significant attention in the scientific community. She has also played a key role in securing funding for her research, having presided over a Natural Science Fund of Jilin Province. Furthermore, her presentation at the ICAS Joint Conference in 2016 earned her the Best Poster Presentation Award, underscoring her ability to communicate complex scientific ideas effectively.

Awards and accolades 🏆

Dr. Sun’s hard work and dedication have been recognized both within and outside her institution. In addition to her prestigious academic background, she received the Best Poster Presentation Award at the ICAS Joint Conference in 2016, an accolade that reflected the quality of her research and its potential to contribute to advancements in medical science. Her growing list of awards includes several recognitions for her academic excellence and commitment to research. These accolades highlight her as one of the leading researchers in the field of cerebrovascular and cognitive disorders, particularly in the area of stroke research.

Future contributions and legacy 🌱

Looking ahead, Dr. Sun’s research trajectory remains focused on unraveling the complexities of stroke, neuroinflammation, and cognitive disorders. She is committed to identifying new therapeutic targets that could lead to more effective treatments for stroke victims and individuals suffering from related neurodegenerative conditions. Her legacy is likely to include groundbreaking discoveries that change the way we understand brain injuries and diseases. As she continues to make strides in her research, Dr. Sun aims to contribute to more personalized and precise medical interventions in neurology. Her career trajectory promises a future where her work will not only influence the scientific community but also provide tangible benefits to patients suffering from cerebrovascular and cognitive disorders.

Mentorship and influence on the next generation of researchers 🌟

Dr. Sun is not just a researcher but also a mentor, dedicated to shaping the next generation of neurologists and scientists. Through her work at the China-Japan Union Hospital of Jilin University, she provides guidance and mentorship to young researchers, particularly those interested in cerebrovascular diseases and neuroinflammation. Her ability to inspire and educate future medical professionals ensures that her impact will extend beyond her own research. By cultivating a culture of excellence and inquiry, Dr. Sun is influencing the next wave of scientific minds who will continue to explore and address the most pressing neurological challenges of our time.

Research impact and clinical applications 💉

Dr. Sun’s research is not only pivotal in the theoretical realm but also holds significant clinical value. Her work has led to the identification of new biomarkers and potential drug targets for treating stroke and related neurovascular disorders. The intersection of her clinical expertise and research in molecular mechanisms positions her to contribute to the development of novel therapeutic approaches. In particular, her studies on neuroinflammation and the NLRP3 inflammasome could lead to more effective treatments for stroke recovery and prevention of long-term cognitive decline. Dr. Sun’s research continues to push the boundaries of both basic science and clinical practice, creating tangible benefits for the treatment of neurological diseases.

📚 Publications

  • Title: The Role of Major Facilitator Superfamily Domain-Containing 2a in the Central Nervous System
    Authors: Zhidong He, Yanan Zhao, Jing Sun
    Year: 2023

 

  • Title: Case Report: Early-Onset Guillain-Barre Syndrome Mimicking Stroke
    Authors: Jing Sun
    Year: 2021

 

  • Title: The Mechanisms of Type 2 Diabetes-Related White Matter Intensities: A Review
    Authors: Jing Sun
    Year: 2020

 

  • Title: NLRP3 Inflammasome Contributes to Neurovascular Unit Damage in Stroke
    Authors: Jing Sun, Lumei Chi, Zhidong He, Yu Gao, Yufei Gao, Yujing Huang, Guangxian Nan
    Year: 2019

 

  • Title: Nonspecific Dizziness as an Unusual Presentation of Neurocysticercosis: A Case Report
    Authors: Jing Sun
    Year: 2019

 

  • Title: Anti-inflammatory Effects of Fimasartan via Akt, ERK, and NFκB Pathways on Astrocytes Stimulated by Hemolysate
    Authors: Jing Sun
    Year: 2016

 

  • Title: Cerebral Venous Sinus Thrombosis Presenting with Multifocal Intracerebral Hemorrhage and Subarachnoid Hemorrhage: A Case Report
    Authors: Jing Sun

 

  • Title: Pretreatment with Low-Dose Fimasartan Ameliorates NLRP3 Inflammasome-Mediated Neuroinflammation and Brain Injury After Intracerebral Hemorrhage
    Authors: Jing Sun

 

  • Title: The Extracellular Signal-Regulated Kinase 1/2 Pathway in Neurological Diseases: A Potential Therapeutic Target (Review)
    Authors: Jing Sun

 

  • Title: The Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway as a Discovery Target in Stroke
    Authors: Jing Sun
    Year: 2016

 

Conclusion

Dr. Jing Sun’s contributions to cerebrovascular and cognitive disorder research have made a lasting impact on both the scientific community and clinical practice. Her innovative work continues to uncover new therapeutic avenues for stroke and neuroinflammatory conditions, advancing our understanding of these complex diseases. As she continues to build on her achievements, Dr. Sun is poised to make even greater contributions to the field, not only through her research but also by inspiring and mentoring future generations of medical professionals and scientists. Her legacy promises to significantly improve the diagnosis, treatment, and prevention of neurological diseases, shaping the future of neurology for years to come.